Home/Filings/4/0001842952-22-000112
4//SEC Filing

Lehr Martin A. 4

Accession 0001842952-22-000112

CIK 0001842952other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:11 PM ET

Size

5.2 KB

Accession

0001842952-22-000112

Insider Transaction Report

Form 4
Period: 2022-12-16
Lehr Martin A.
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-12-16$0.74/sh+20,000$14,796122,583 total
Holdings
  • Common Stock

    (indirect: By Trust)
    820,190

Issuer

Context Therapeutics Inc.

CIK 0001842952

Entity typeother

Related Parties

1
  • filerCIK 0001861989

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:11 PM ET
Size
5.2 KB